TSUMURA & CO. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,950 JPY | +3.40% |
|
+2.15% | +48.69% |
Presenter SpeechTerukazu Kato (Executives)Good afternoon. I am Kato. Thank you very much for c...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
TSUMURA & CO. is a Japan-based company mainly engaged in the manufacture and sale of ethical and general pharmaceuticals. Through its subsidiaries, the Company is also engaged in the procurement, sorting and processing of crude drugs, the manufacture and sale of Chinese herbal extract powders and drug substances, the operation of dispensing pharmacies and the provision of logistics services, as well as the development of pharmaceuticals.
Sector
Pharmaceuticals
Calendar
06/11/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3,950
JPY
Average target price
5,150
JPY
Spread / Average Target
+30.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +48.69% | 1.91B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 4540 Stock
- News Tsumura & Co.
- Transcript : Tsumura & Co., H1 2018 Earnings Call, Nov 09, 2017
